Verywell Health on MSN1y
Lung Cancer Liver Metastasis
Medically reviewed by Gagandeep Brar, MD Lung cancer liver metastases are tumors that form in the liver from cancer cells ...
The American Journal of Managed Care6d
Non-Small Cell Lung Cancer
The FDA approved the FoundationOne Liquid CDx to identify patients with metastatic non–small cell lung cancer (mNSCLC) with MET exon 14 skipping alterations who may be eligible for tepotinib ...
Cure Today14d
FDA Grants Breakthrough Therapy Designation to Trodelvy for Small Cell Lung Cancer
The FDA has granted breakthrough therapy designation Trodelvy for adults with extensive-stage small cell lung cancer who ...
WebMD29d
FDA Approves Drug for Aggressive Small-Cell Lung Cancer
The FDA has approved the drug durvalumab for adults with limited-stage small-cell ... cancer cells more effectively. Imfinzi was first approved by the FDA in 2017 for use against various lung ...
2minutemedicine.com8d
AstraZeneca’s Imfinzi shows positive results in phase 3 trial for treatment of limited-stage small cell lung cancer
Imfinzi reduced risk of death by 27% and reduced disease progression by 24% compared to patients receiving a placebo. 2. In ...
Pharmaceutical Technology7d
Envafolimab by Alphamab Oncology for Non-Small Cell Lung Cancer: Likelihood of Approval
Envafolimab is under clinical development by Alphamab Oncology and currently in Phase I for Non-Small Cell Lung Cancer.
Pharmaceutical Technology8d
Catequentinib hydrochloride by Advenchen Laboratories for Non-Small Cell Lung Cancer: Likelihood of Approval
Catequentinib hydrochloride is under clinical development by Advenchen Laboratories and currently in Phase II for Non-Small Cell Lung Cancer.